Detalhe da pesquisa
1.
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience.
Ann Rheum Dis
; 81(10): e188, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32732244